Multiple myeloma is a type of cancer that begins in plasma cells (white blood cells that produce antibodies). Also called Kahler disease, myelomatosis, and plasma cell myeloma.
Different treatments are available for those with multiple myeloma. Some treatments are called standard. This means they are the currently used treatments. Some treatments are being tested in clinical trials. A treatment clinical trial is a study meant to help improve current treatments or obtain information on new treatments.
When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. You may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment, while others are available during or after treatment.
Treatment options vary depending on your situation including the stage of the cancer and other factors that may be...
Immediately after being told by his primary care physician that the Abramson Cancer Center is one of the best cancer institutions in the country, Andrew Vartanian made his first appointment.
Stand Up to Cancer
Stand Up 2 Cancer Concert To Return to Networks on September 10, 2010. Craig Thompson, MD, director of the Abramson Cancer Center, discusses plans for a second Stand Up 2 Cancer concert. Read more
Find a Doctor/Researcher
Make an Appointment
Refer a Patient
Make a Gift
Explore Penn Cancer Network
